Intravenous artificial oxygen carriers

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2003 United Kingdom English Publisher:Mark Allen GroupJournal:Hospital Medicine, volume 64, pages 352-356 (issn: 1462-3935, eissn: 2053-4299,

Copyright policy )

Authors: Grocott, Mike; Farrar, Daniel;

doi: 10.12968/hosp.2003.64.6.352

pmid: 12833830

Intravenous artificial oxygen carriers

- Summary
- Subjects
- Metrics

Abstract

Haemoglobin-based oxygen carriers and perfluorocarbons have been developed as artificial oxygen carriers which can be safely administered intravenously. Mixed results from clinical trials to date suggest that further work is required to clearly demonstrate clinical efficacy and safety for these exciting products.

Country

United Kingdom

Related Organizations

University College London
United Kingdom
University of Southampton
United Kingdom

Keywords

Oxygen, Clinical Trials as Topic, Fluorocarbons, Hemoglobins, Blood Substitutes, 610, Humans, Infusions, Intravenous, Forecasting

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	18
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average